# GREAT Version 5.03
# Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension
# Significance tests required to pass thresholds: both
# Raw P-val tolerated: 5.000000e-02
# Annotation count range: [1, -1]
# DAG level range: [1, -1]
# Tests performed: 6074
# ID	Desc	DAGLvl	BRank	BPval	BBonf	BFDR	BFold	BExp	Bn	Bk	BProb	RegionSetCov	HRank	HPval	HBonf	HFDR	HFold	HExp	HN	HK	Hn	Hk	GeneSetCov	TermGeneCov	Genes	Regions
MP:0005374	lethality-prenatal/perinatal	2	2	2.009172e-55	1.220371e-51	6.101857e-52	4.821612e+01	8.710780e-01	556	42	1.566687e-03	7.553957e-02	17	1.287723e-02	1.000000e+00	1.000000e+00	1.434211e+00	2.719266e+01	17217	2018	232	39	1.681034e-01	1.932607e-02	ACTB,ACTG1,ARHGAP1,ARID3B,AURKA,B4GALT1,CSNK2B,CSRP2BP,DPH1,EBF3,EGR2,EIF4G2,EIF6,FDFT1,FOS,FOSL1,HDAC3,JUNB,KAT5,MCL1,MEIS1,MORC3,MOSPD3,MTTP,NR2F2,NR4A2,NR4A3,OFD1,PEX14,PFN1,POLD1,RBM19,RPL24,SRF,STX4,TMED10,UPF2,VEZT,WDR1	SRF.104,SRF.11,SRF.137,SRF.139,SRF.176,SRF.209,SRF.231,SRF.232,SRF.25,SRF.274,SRF.279,SRF.302,SRF.35,SRF.356,SRF.363,SRF.365,SRF.369,SRF.37,SRF.370,SRF.39,SRF.4,SRF.407,SRF.416,SRF.428,SRF.43,SRF.434,SRF.446,SRF.45,SRF.450,SRF.459,SRF.470,SRF.471,SRF.493,SRF.52,SRF.526,SRF.53,SRF.54,SRF.64,SRF.85,SRF.87,SRF.97,SRF.99
MP:0002080	prenatal lethality	3	4	5.200073e-42	3.158524e-38	7.896311e-39	5.121230e+01	6.053233e-01	556	31	1.088711e-03	5.575540e-02	25	1.873158e-02	1.000000e+00	1.000000e+00	1.484224e+00	2.021258e+01	17217	1500	232	30	1.293103e-01	2.000000e-02	ACTB,ARID3B,AURKA,CSNK2B,CSRP2BP,DPH1,EIF4G2,EIF6,FDFT1,FOSL1,HDAC3,JUNB,KAT5,MCL1,MEIS1,MTTP,NR2F2,NR4A3,OFD1,PEX14,PFN1,POLD1,RBM19,RPL24,SRF,STX4,TMED10,UPF2,VEZT,WDR1	SRF.104,SRF.11,SRF.137,SRF.139,SRF.176,SRF.209,SRF.231,SRF.232,SRF.274,SRF.279,SRF.35,SRF.356,SRF.363,SRF.365,SRF.369,SRF.370,SRF.4,SRF.407,SRF.416,SRF.428,SRF.434,SRF.446,SRF.45,SRF.470,SRF.493,SRF.526,SRF.53,SRF.54,SRF.64,SRF.85,SRF.87
MP:0008762	embryonic lethality	4	6	9.961980e-41	6.050907e-37	1.008484e-37	6.394882e+01	4.378501e-01	556	28	7.875002e-04	5.035971e-02	3	2.018329e-03	1.000000e+00	1.000000e+00	1.811666e+00	1.490341e+01	17217	1106	232	27	1.163793e-01	2.441230e-02	ACTB,ARID3B,AURKA,CSNK2B,CSRP2BP,DPH1,EIF4G2,EIF6,FDFT1,FOSL1,HDAC3,KAT5,MEIS1,MTTP,NR2F2,NR4A3,OFD1,PFN1,POLD1,RBM19,RPL24,SRF,STX4,TMED10,UPF2,VEZT,WDR1	SRF.104,SRF.137,SRF.139,SRF.176,SRF.209,SRF.231,SRF.232,SRF.274,SRF.279,SRF.35,SRF.356,SRF.363,SRF.365,SRF.369,SRF.370,SRF.4,SRF.407,SRF.416,SRF.434,SRF.446,SRF.45,SRF.470,SRF.493,SRF.526,SRF.53,SRF.54,SRF.64,SRF.85
MP:0001672	abnormal embryogenesis/ development	3	7	1.055680e-39	6.412203e-36	9.160290e-37	5.870325e+01	4.769753e-01	556	28	8.578692e-04	5.035971e-02	5	5.160317e-03	1.000000e+00	1.000000e+00	1.712060e+00	1.518639e+01	17217	1127	232	26	1.120690e-01	2.307010e-02	ACTB,ARHGAP1,ARID3B,AURKA,CSNK2B,CSRP2BP,DPH1,EIF4G2,FDFT1,FOS,FOSL1,HDAC3,HMX3,JUNB,MCL1,MEGF8,MTTP,NR2F2,NR4A3,OFD1,PFN1,POLD1,RBM19,RPL24,SRF,VEZT	SRF.104,SRF.11,SRF.137,SRF.139,SRF.176,SRF.209,SRF.231,SRF.232,SRF.274,SRF.279,SRF.35,SRF.356,SRF.365,SRF.369,SRF.37,SRF.370,SRF.382,SRF.39,SRF.4,SRF.407,SRF.434,SRF.459,SRF.493,SRF.526,SRF.53,SRF.61,SRF.64,SRF.87
MP:0005384	cellular phenotype	2	14	3.928851e-35	2.386384e-31	1.704560e-32	6.413399e+01	3.742165e-01	556	24	6.730513e-04	4.316547e-02	51	3.135214e-02	1.000000e+00	1.000000e+00	1.511831e+00	1.521334e+01	17217	1129	232	23	9.913793e-02	2.037201e-02	ARHGAP1,ARID3B,AURKA,B4GALT1,BTRC,CSRP2BP,DPH1,EIF4G2,EIF6,GADD45G,HDAC3,ING1,IRF3,KAT5,MTTP,RAPGEF6,RBM19,RPL24,RPL38,SRF,TMED10,VEZT,ZYX	SRF.13,SRF.137,SRF.139,SRF.209,SRF.231,SRF.252,SRF.298,SRF.356,SRF.365,SRF.369,SRF.37,SRF.370,SRF.388,SRF.393,SRF.416,SRF.434,SRF.436,SRF.438,SRF.470,SRF.493,SRF.526,SRF.53,SRF.54,SRF.97
MP:0005621	abnormal cell physiology	3	19	2.145674e-32	1.303283e-28	6.859382e-30	6.464922e+01	3.402980e-01	556	22	6.120468e-04	3.956835e-02	59	3.586048e-02	1.000000e+00	1.000000e+00	1.524888e+00	1.377150e+01	17217	1022	232	21	9.051724e-02	2.054795e-02	ARHGAP1,ARID3B,AURKA,B4GALT1,BTRC,CSRP2BP,DPH1,EIF4G2,EIF6,GADD45G,HDAC3,ING1,IRF3,KAT5,MTTP,RAPGEF6,RPL24,RPL38,SRF,VEZT,ZYX	SRF.13,SRF.137,SRF.139,SRF.209,SRF.231,SRF.252,SRF.298,SRF.356,SRF.365,SRF.369,SRF.37,SRF.370,SRF.388,SRF.393,SRF.436,SRF.438,SRF.470,SRF.493,SRF.526,SRF.53,SRF.54,SRF.97
MP:0002088	abnormal embryonic growth/weight/body size	4	41	1.385426e-23	8.415077e-20	2.052458e-21	6.135497e+01	2.607776e-01	556	16	4.690244e-04	2.877698e-02	46	2.869346e-02	1.000000e+00	1.000000e+00	1.725842e+00	8.691410e+00	17217	645	232	15	6.465517e-02	2.325581e-02	ACTB,ARHGAP1,ARID3B,CSNK2B,CSRP2BP,DPH1,EIF4G2,FDFT1,FOSL1,JUNB,NR4A3,OFD1,PFN1,RPL24,SRF	SRF.11,SRF.137,SRF.139,SRF.176,SRF.209,SRF.231,SRF.232,SRF.274,SRF.279,SRF.356,SRF.37,SRF.4,SRF.407,SRF.526,SRF.53,SRF.64
MP:0002221	abnormal lymph organ size	5	50	1.288887e-22	7.828702e-19	1.565740e-20	6.547544e+01	2.290935e-01	556	15	4.120387e-04	2.697842e-02	58	3.511017e-02	1.000000e+00	1.000000e+00	1.717284e+00	8.152408e+00	17217	605	232	14	6.034483e-02	2.314050e-02	ARHGAP1,B4GALT1,FOS,GADD45G,GIMAP5,ING1,MCL1,NR4A1,NR4A3,POLD1,RAPGEF6,RPL22,TCF7,UPF2	SRF.104,SRF.176,SRF.21,SRF.268,SRF.298,SRF.36,SRF.363,SRF.364,SRF.37,SRF.39,SRF.436,SRF.438,SRF.459,SRF.87,SRF.97
MP:0002020	increased tumor incidence	5	52	1.957714e-21	1.189116e-17	2.286761e-19	8.795910e+01	1.477960e-01	556	13	2.658201e-04	2.338129e-02	16	1.287258e-02	1.000000e+00	1.000000e+00	2.095375e+00	5.726898e+00	17217	425	232	12	5.172414e-02	2.823529e-02	ACTB,AURKA,DPH1,FOS,GSTP1,ING1,IQGAP1,JUNB,KAT5,NR4A1,NR4A3,POLD1	SRF.104,SRF.11,SRF.161,SRF.166,SRF.176,SRF.209,SRF.21,SRF.365,SRF.39,SRF.4,SRF.438,SRF.459,SRF.54
MP:0002019	abnormal tumor incidence	4	54	5.727916e-21	3.479136e-17	6.442845e-19	8.091443e+01	1.606636e-01	556	13	2.889632e-04	2.338129e-02	44	2.784787e-02	1.000000e+00	1.000000e+00	1.874809e+00	6.400651e+00	17217	475	232	12	5.172414e-02	2.526316e-02	ACTB,AURKA,DPH1,FOS,GSTP1,ING1,IQGAP1,JUNB,KAT5,NR4A1,NR4A3,POLD1	SRF.104,SRF.11,SRF.161,SRF.166,SRF.176,SRF.209,SRF.21,SRF.365,SRF.39,SRF.4,SRF.438,SRF.459,SRF.54
MP:0002166	altered tumor susceptibility	3	56	1.337184e-20	8.122058e-17	1.450368e-18	7.574805e+01	1.716216e-01	556	13	3.086719e-04	2.338129e-02	83	4.971093e-02	1.000000e+00	1.000000e+00	1.712566e+00	7.007028e+00	17217	520	232	12	5.172414e-02	2.307692e-02	ACTB,AURKA,DPH1,FOS,GSTP1,ING1,IQGAP1,JUNB,KAT5,NR4A1,NR4A3,POLD1	SRF.104,SRF.11,SRF.161,SRF.166,SRF.176,SRF.209,SRF.21,SRF.365,SRF.39,SRF.4,SRF.438,SRF.459,SRF.54
MP:0000313	abnormal cell death	4	59	2.036157e-20	1.236762e-16	2.096207e-18	7.330790e+01	1.773342e-01	556	13	3.189464e-04	2.338129e-02	77	4.515959e-02	1.000000e+00	1.000000e+00	1.739325e+00	6.899228e+00	17217	512	232	12	5.172414e-02	2.343750e-02	ARHGAP1,ARID3B,AURKA,BTRC,CSRP2BP,HDAC3,ING1,IRF3,MTTP,RPL24,RPL38,SRF	SRF.13,SRF.137,SRF.139,SRF.231,SRF.356,SRF.365,SRF.369,SRF.37,SRF.388,SRF.393,SRF.438,SRF.493,SRF.53
MP:0001648	abnormal apoptosis	5	60	2.134918e-20	1.296749e-16	2.161249e-18	9.697692e+01	1.237408e-01	556	12	2.225554e-04	2.158273e-02	8	7.599401e-03	1.000000e+00	1.000000e+00	2.352517e+00	4.675844e+00	17217	347	232	11	4.741379e-02	3.170029e-02	ARHGAP1,ARID3B,AURKA,BTRC,CSRP2BP,HDAC3,ING1,IRF3,RPL24,RPL38,SRF	SRF.13,SRF.137,SRF.139,SRF.231,SRF.356,SRF.365,SRF.37,SRF.388,SRF.393,SRF.438,SRF.493,SRF.53
MP:0008250	abnormal myeloid leukocyte morphology	6	63	5.411808e-20	3.287132e-16	5.217670e-18	8.967591e+01	1.338152e-01	556	12	2.406748e-04	2.158273e-02	61	3.767129e-02	1.000000e+00	1.000000e+00	1.846885e+00	5.955974e+00	17217	442	232	11	4.741379e-02	2.488688e-02	B4GALT1,B9D2,CNN2,FOS,GIMAP5,JUNB,MCL1,NR4A1,NR4A3,UPF2,WDR1	SRF.11,SRF.176,SRF.21,SRF.363,SRF.364,SRF.39,SRF.45,SRF.459,SRF.556,SRF.82,SRF.87,SRF.97
MP:0006042	increased apoptosis	6	95	3.474350e-16	2.110320e-12	2.221390e-14	1.115799e+02	8.065968e-02	556	9	1.450714e-04	1.618705e-02	4	2.950946e-03	1.000000e+00	1.000000e+00	3.049776e+00	2.951037e+00	17217	219	232	9	3.879310e-02	4.109589e-02	ARHGAP1,ARID3B,AURKA,BTRC,CSRP2BP,HDAC3,ING1,RPL24,RPL38	SRF.137,SRF.231,SRF.356,SRF.365,SRF.37,SRF.388,SRF.393,SRF.438,SRF.493
MP:0000703	abnormal thymus morphology	4	101	1.010144e-15	6.135617e-12	6.074868e-14	6.829288e+01	1.464282e-01	556	10	2.633600e-04	1.798561e-02	73	4.009337e-02	1.000000e+00	1.000000e+00	1.976038e+00	4.554568e+00	17217	338	232	9	3.879310e-02	2.662722e-02	ARHGAP1,FOS,MCL1,NR4A1,NR4A3,POLD1,RPL22,TCF7,UPF2	SRF.104,SRF.176,SRF.21,SRF.268,SRF.36,SRF.363,SRF.37,SRF.39,SRF.459,SRF.87
MP:0003077	abnormal cell cycle	4	102	1.627022e-15	9.882531e-12	9.688755e-14	1.481364e+02	5.400430e-02	556	8	9.713003e-05	1.438849e-02	2	1.806812e-03	1.000000e+00	1.000000e+00	3.598119e+00	2.223384e+00	17217	165	232	8	3.448276e-02	4.848485e-02	AURKA,B4GALT1,BTRC,CSRP2BP,EIF6,HDAC3,ING1,RPL24	SRF.137,SRF.231,SRF.365,SRF.388,SRF.438,SRF.470,SRF.493,SRF.97
MP:0002441	abnormal granulocyte morphology	7	118	4.009640e-14	2.435455e-10	2.063945e-12	9.895137e+01	8.084780e-02	556	8	1.454097e-04	1.438849e-02	29	2.302289e-02	1.000000e+00	1.000000e+00	2.319100e+00	3.449614e+00	17217	256	232	8	3.448276e-02	3.125000e-02	B4GALT1,CNN2,GIMAP5,MCL1,NR4A1,NR4A3,UPF2,WDR1	SRF.176,SRF.21,SRF.363,SRF.364,SRF.45,SRF.82,SRF.87,SRF.97
MP:0001695	abnormal gastrulation	5	130	1.576226e-13	9.574000e-10	7.364615e-12	8.324976e+01	9.609637e-02	556	8	1.728352e-04	1.438849e-02	34	2.561750e-02	1.000000e+00	1.000000e+00	2.438866e+00	2.870186e+00	17217	213	232	7	3.017241e-02	3.286385e-02	DPH1,EIF4G2,HDAC3,MEGF8,NR4A3,OFD1,SRF	SRF.139,SRF.176,SRF.209,SRF.279,SRF.493,SRF.526,SRF.53,SRF.61
MP:0000715	decreased thymocyte number	10	133	2.648509e-13	1.608704e-09	1.209552e-11	1.281189e+02	5.463674e-02	556	7	9.826752e-05	1.258993e-02	30	2.326224e-02	1.000000e+00	1.000000e+00	3.092134e+00	1.617006e+00	17217	120	232	5	2.155172e-02	4.166667e-02	FOS,ING1,MCL1,SRF,TCF7	SRF.139,SRF.36,SRF.39,SRF.438,SRF.459,SRF.53,SRF.87
MP:0000358	abnormal cell content/ morphology	3	143	1.568683e-12	9.528180e-09	6.663063e-11	9.917384e+01	7.058313e-02	556	7	1.269481e-04	1.258993e-02	65	3.883004e-02	1.000000e+00	1.000000e+00	2.229521e+00	3.139688e+00	17217	233	232	7	3.017241e-02	3.004292e-02	ARHGAP1,AURKA,BTRC,HDAC3,RBM19,TMED10,ZYX	SRF.252,SRF.365,SRF.37,SRF.388,SRF.416,SRF.434,SRF.493
MP:0000165	abnormal long bone hypertrophic chondrocyte zone	6	152	8.424689e-12	5.117156e-08	3.366550e-10	1.390154e+02	4.316068e-02	556	6	7.762712e-05	1.079137e-02	56	3.340696e-02	1.000000e+00	1.000000e+00	3.298276e+00	1.212755e+00	17217	90	232	4	1.724138e-02	4.444444e-02	EGR2,FOS,FOSL2,PFN1	SRF.232,SRF.25,SRF.39,SRF.459,SRF.52,SRF.84
MP:0008079	decreased CD8-positive T cell number	10	153	9.183022e-12	5.577767e-08	3.645600e-10	1.370206e+02	4.378904e-02	556	6	7.875726e-05	1.079137e-02	48	2.965989e-02	1.000000e+00	1.000000e+00	2.898875e+00	1.724807e+00	17217	128	232	5	2.155172e-02	3.906250e-02	GIMAP5,MCL1,RPL22,SRF,UPF2	SRF.139,SRF.268,SRF.363,SRF.364,SRF.53,SRF.87
MP:0008075	decreased CD4-positive T cell number	10	159	1.649604e-11	1.001970e-07	6.301695e-10	1.241965e+02	4.831052e-02	556	6	8.688943e-05	1.079137e-02	55	3.323634e-02	1.000000e+00	1.000000e+00	2.811031e+00	1.778707e+00	17217	132	232	5	2.155172e-02	3.787879e-02	GIMAP5,MCL1,RPL22,SRF,UPF2	SRF.139,SRF.268,SRF.363,SRF.364,SRF.53,SRF.87
MP:0005065	abnormal neutrophil morphology	8	161	1.947129e-11	1.182686e-07	7.345878e-10	1.207879e+02	4.967385e-02	556	6	8.934146e-05	1.079137e-02	23	1.518785e-02	1.000000e+00	1.000000e+00	3.008562e+00	1.994308e+00	17217	148	232	6	2.586207e-02	4.054054e-02	B4GALT1,CNN2,MCL1,NR4A1,NR4A3,WDR1	SRF.176,SRF.21,SRF.45,SRF.82,SRF.87,SRF.97
MP:0000322	increased granulocyte number	8	166	4.683195e-11	2.844572e-07	1.713598e-09	1.042354e+02	5.756203e-02	556	6	1.035288e-04	1.079137e-02	50	3.067595e-02	1.000000e+00	1.000000e+00	2.559007e+00	2.344659e+00	17217	174	232	6	2.586207e-02	3.448276e-02	B4GALT1,GIMAP5,MCL1,NR4A1,NR4A3,WDR1	SRF.176,SRF.21,SRF.364,SRF.45,SRF.87,SRF.97
MP:0008321	small adenohypophysis	7	187	3.705740e-10	2.250867e-06	1.203672e-08	4.099899e+02	9.756339e-03	556	4	1.754737e-05	7.194245e-03	1	1.697028e-03	1.000000e+00	1.000000e+00	1.236853e+01	2.425510e-01	17217	18	232	3	1.293103e-02	1.666667e-01	B4GALT1,EGR1,HMX3	SRF.2,SRF.3,SRF.382,SRF.97
MP:0006204	embryonic lethality before implantation	5	193	5.298959e-10	3.218588e-06	1.667662e-08	1.361747e+02	3.671754e-02	556	5	6.603873e-05	8.992806e-03	27	2.181623e-02	1.000000e+00	1.000000e+00	3.144543e+00	1.590056e+00	17217	118	232	5	2.155172e-02	4.237288e-02	AURKA,EIF6,KAT5,PFN1,TMED10	SRF.232,SRF.365,SRF.416,SRF.470,SRF.54
MP:0004067	abnormal ventricular trabeculae morphology	6	194	5.436396e-10	3.302067e-06	1.702096e-08	1.354749e+02	3.690721e-02	556	5	6.637988e-05	8.992806e-03	24	1.618777e-02	1.000000e+00	1.000000e+00	4.122845e+00	9.702039e-01	17217	72	232	4	1.724138e-02	5.555556e-02	MEGF8,MOSPD3,NR2F2,SRF	SRF.139,SRF.35,SRF.471,SRF.53,SRF.61
MP:0000172	abnormal bone marrow cell number	5	211	2.159366e-09	1.311599e-05	6.216110e-08	1.026145e+02	4.872606e-02	556	5	8.763679e-05	8.992806e-03	26	2.111571e-02	1.000000e+00	1.000000e+00	3.171419e+00	1.576581e+00	17217	117	232	5	2.155172e-02	4.273504e-02	ARHGAP1,CNN2,MEIS1,NR4A1,NR4A3	SRF.176,SRF.21,SRF.37,SRF.446,SRF.82
MP:0004046	abnormal mitosis	5	214	2.342581e-09	1.422884e-05	6.648989e-08	2.582701e+02	1.548766e-02	556	4	2.785550e-05	7.194245e-03	9	8.689358e-03	1.000000e+00	1.000000e+00	4.947414e+00	8.085032e-01	17217	60	232	4	1.724138e-02	6.666667e-02	AURKA,B4GALT1,BTRC,EIF6	SRF.365,SRF.388,SRF.470,SRF.97
MP:0004907	abnormal seminal vesicle size	6	229	5.811318e-09	3.529795e-05	1.541395e-07	2.056305e+02	1.945237e-02	556	4	3.498628e-05	7.194245e-03	31	2.396652e-02	1.000000e+00	1.000000e+00	4.839861e+00	6.198525e-01	17217	46	232	3	1.293103e-02	6.521739e-02	ACTB,EGR1,VGF	SRF.2,SRF.3,SRF.338,SRF.4
MP:0000134	abnormal cortical bone thickness	7	230	5.883439e-09	3.573601e-05	1.553739e-07	2.049949e+02	1.951268e-02	556	4	3.509474e-05	7.194245e-03	45	2.825104e-02	1.000000e+00	1.000000e+00	4.543543e+00	6.602776e-01	17217	49	232	3	1.293103e-02	6.122449e-02	ARHGAP1,FOS,JUNB	SRF.11,SRF.37,SRF.39,SRF.459
MP:0004983	abnormal osteoclast cell number	6	231	6.371897e-09	3.870290e-05	1.675450e-07	2.009323e+02	1.990720e-02	556	4	3.580432e-05	7.194245e-03	78	4.716987e-02	1.000000e+00	1.000000e+00	3.710560e+00	8.085032e-01	17217	60	232	3	1.293103e-02	5.000000e-02	FOS,JUNB,WDR1	SRF.11,SRF.39,SRF.45,SRF.459
MP:0003194	abnormal frequency of paradoxical sleep	5	232	6.430896e-09	3.906126e-05	1.683675e-07	8.854531e+02	3.388096e-03	556	3	6.093698e-06	5.395683e-03	6	6.115086e-03	1.000000e+00	1.000000e+00	1.649138e+01	1.212755e-01	17217	9	232	2	8.620690e-03	2.222222e-01	FOS,FOSB	SRF.39,SRF.40,SRF.459
MP:0003111	abnormal nucleus morphology	4	238	1.017118e-08	6.177973e-05	2.595787e-07	1.786736e+02	2.238719e-02	556	4	4.026473e-05	7.194245e-03	47	2.892614e-02	1.000000e+00	1.000000e+00	3.451684e+00	1.158855e+00	17217	86	232	4	1.724138e-02	4.651163e-02	ARHGAP1,AURKA,BTRC,RBM19	SRF.365,SRF.37,SRF.388,SRF.434
MP:0000295	poorly developed ventricular trabeculae	6	250	1.912643e-08	1.161739e-04	4.646956e-07	1.524625e+02	2.623596e-02	556	4	4.718697e-05	7.194245e-03	57	3.455265e-02	1.000000e+00	1.000000e+00	4.200634e+00	7.141778e-01	17217	53	232	3	1.293103e-02	5.660377e-02	MEGF8,MOSPD3,SRF	SRF.139,SRF.471,SRF.53,SRF.61
MP:0004163	abnormal adenohypophysis morphology	6	251	2.189506e-08	1.329906e-04	5.298430e-07	1.473693e+02	2.714270e-02	556	4	4.881781e-05	7.194245e-03	62	3.795326e-02	1.000000e+00	1.000000e+00	4.047884e+00	7.411280e-01	17217	55	232	3	1.293103e-02	5.454545e-02	B4GALT1,EGR1,HMX3	SRF.2,SRF.3,SRF.382,SRF.97
MP:0004905	decreased uterus weight	10	258	2.972358e-08	1.805410e-04	6.997714e-07	5.312657e+02	5.646891e-03	556	3	1.015628e-05	5.395683e-03	15	1.278783e-02	1.000000e+00	1.000000e+00	1.141711e+01	1.751757e-01	17217	13	232	2	8.620690e-03	1.538462e-01	EGR1,VGF	SRF.2,SRF.3,SRF.338
MP:0004808	abnormal hematopoietic stem cell morphology	4	267	3.977648e-08	2.416023e-04	9.048776e-07	1.268259e+02	3.153929e-02	556	4	5.672534e-05	7.194245e-03	12	9.202970e-03	1.000000e+00	1.000000e+00	4.866309e+00	8.219783e-01	17217	61	232	4	1.724138e-02	6.557377e-02	ARHGAP1,NR4A1,NR4A3,UPF2	SRF.176,SRF.21,SRF.363,SRF.37
MP:0004903	abnormal uterus weight	9	285	9.494885e-08	5.767193e-04	2.023577e-06	3.604902e+02	8.322001e-03	556	3	1.496763e-05	5.395683e-03	63	3.798658e-02	1.000000e+00	1.000000e+00	6.453148e+00	3.099262e-01	17217	23	232	2	8.620690e-03	8.695652e-02	EGR1,VGF	SRF.2,SRF.3,SRF.338
MP:0009711	abnormal conditioned place preference behavior	6	286	9.956675e-08	6.047684e-04	2.114575e-06	3.548169e+02	8.455066e-03	556	3	1.520695e-05	5.395683e-03	74	4.107935e-02	1.000000e+00	1.000000e+00	6.184267e+00	3.234013e-01	17217	24	232	2	8.620690e-03	8.333333e-02	FOS,HOMER1	SRF.26,SRF.39,SRF.459
MP:0000562	polydactyly	7	287	1.055663e-07	6.412100e-04	2.234181e-06	9.919196e+01	4.032585e-02	556	4	7.252851e-05	7.194245e-03	28	2.199394e-02	1.000000e+00	1.000000e+00	3.757529e+00	1.064529e+00	17217	79	232	4	1.724138e-02	5.063291e-02	DPH1,MEGF8,OFD1,RPL24	SRF.137,SRF.209,SRF.279,SRF.61
MP:0001132	absent mature ovarian follicles	8	293	1.428651e-07	8.677626e-04	2.961647e-06	3.144971e+02	9.539039e-03	556	3	1.715654e-05	5.395683e-03	76	4.426341e-02	1.000000e+00	1.000000e+00	5.936897e+00	3.368763e-01	17217	25	232	2	8.620690e-03	8.000000e-02	EGR1,VGF	SRF.2,SRF.3,SRF.338
MP:0003566	abnormal cell adhesion	4	296	1.794936e-07	1.090244e-03	3.683257e-06	2.914031e+02	1.029502e-02	556	3	1.851622e-05	5.395683e-03	10	8.981720e-03	1.000000e+00	1.000000e+00	6.957301e+00	4.312017e-01	17217	32	232	3	1.293103e-02	9.375000e-02	RAPGEF6,VEZT,ZYX	SRF.252,SRF.370,SRF.436
MP:0000066	osteoporosis	6	314	2.603588e-07	1.581419e-03	5.036367e-06	2.573392e+02	1.165777e-02	556	3	2.096720e-05	5.395683e-03	22	1.440202e-02	1.000000e+00	1.000000e+00	5.858779e+00	5.120520e-01	17217	38	232	3	1.293103e-02	7.894737e-02	ARHGAP1,FHL2,FOSL1	SRF.37,SRF.49,SRF.64
MP:0005011	increased eosinophil cell number	8	341	7.246468e-07	4.401505e-03	1.290764e-05	1.827290e+02	1.641775e-02	556	3	2.952833e-05	5.395683e-03	60	3.623229e-02	1.000000e+00	1.000000e+00	4.122845e+00	7.276529e-01	17217	54	232	3	1.293103e-02	5.555556e-02	MCL1,NR4A1,NR4A3	SRF.176,SRF.21,SRF.87
MP:0008155	decreased diameter of radius	7	351	1.081073e-06	6.566437e-03	1.870780e-05	1.358264e+03	1.472468e-03	556	2	2.648323e-06	3.597122e-03	36	2.676930e-02	1.000000e+00	1.000000e+00	3.710560e+01	2.695011e-02	17217	2	232	1	4.310345e-03	5.000000e-01	EGR2	SRF.25,SRF.52
MP:0002976	vascular smooth muscle hypotrophy	6	356	1.276477e-06	7.753321e-03	2.177899e-05	1.249933e+03	1.600086e-03	556	2	2.877852e-06	3.597122e-03	66	3.988516e-02	1.000000e+00	1.000000e+00	2.473707e+01	4.042516e-02	17217	3	232	1	4.310345e-03	3.333333e-01	SRF	SRF.139,SRF.53
MP:0002026	leukemia	6	359	1.332254e-06	8.092111e-03	2.254070e-05	1.490230e+02	2.013112e-02	556	3	3.620705e-05	5.395683e-03	49	2.976358e-02	1.000000e+00	1.000000e+00	4.452672e+00	6.737527e-01	17217	50	232	3	1.293103e-02	6.000000e-02	JUNB,NR4A1,NR4A3	SRF.11,SRF.176,SRF.21
MP:0001070	abnormal abducens nerve morphology	6	366	1.715537e-06	1.042017e-02	2.847042e-05	1.078094e+03	1.855126e-03	556	2	3.336558e-06	3.597122e-03	66	3.988516e-02	1.000000e+00	1.000000e+00	2.473707e+01	4.042516e-02	17217	3	232	1	4.310345e-03	3.333333e-01	EGR2	SRF.25,SRF.52
MP:0004016	decreased bone mass	5	372	1.872314e-06	1.137244e-02	3.057107e-05	1.329619e+02	2.256286e-02	556	3	4.058068e-05	5.395683e-03	82	4.913368e-02	1.000000e+00	1.000000e+00	3.649731e+00	8.219783e-01	17217	61	232	3	1.293103e-02	4.918033e-02	ARHGAP1,FHL2,FOSL1	SRF.37,SRF.49,SRF.64
MP:0000600	liver hypoplasia	7	382	2.363744e-06	1.435738e-02	3.758477e-05	1.229670e+02	2.439678e-02	556	3	4.387910e-05	5.395683e-03	33	2.535243e-02	1.000000e+00	1.000000e+00	4.736886e+00	6.333275e-01	17217	47	232	3	1.293103e-02	6.382979e-02	ARHGAP1,EIF6,MEIS1	SRF.37,SRF.446,SRF.470
MP:0004760	increased mitotic index	6	400	3.571549e-06	2.169359e-02	5.423398e-05	7.469811e+02	2.677444e-03	556	2	4.815547e-06	3.597122e-03	6	6.115086e-03	1.000000e+00	1.000000e+00	1.649138e+01	1.212755e-01	17217	9	232	2	8.620690e-03	2.222222e-01	AURKA,B4GALT1	SRF.365,SRF.97
MP:0008527	embryonic lethality at implantation	5	416	6.609688e-06	4.014725e-02	9.650781e-05	5.489188e+02	3.643526e-03	556	2	6.553104e-06	3.597122e-03	11	9.178152e-03	1.000000e+00	1.000000e+00	1.349295e+01	1.482256e-01	17217	11	232	2	8.620690e-03	1.818182e-01	ACTB,VEZT	SRF.370,SRF.4
MP:0009760	abnormal mitotic spindle	6	428	9.300003e-06	5.648822e-02	1.319818e-04	4.626570e+02	4.322857e-03	556	2	7.774923e-06	3.597122e-03	13	1.091664e-02	1.000000e+00	1.000000e+00	1.236853e+01	1.617006e-01	17217	12	232	2	8.620690e-03	1.666667e-01	AURKA,BTRC	SRF.365,SRF.388
MP:0003694	failure to hatch from the zona pellucida	5	454	1.765826e-05	1.072563e-01	2.362473e-04	3.355758e+02	5.959905e-03	556	2	1.071925e-05	3.597122e-03	63	3.798658e-02	1.000000e+00	1.000000e+00	6.453148e+00	3.099262e-01	17217	23	232	2	8.620690e-03	8.695652e-02	AURKA,VEZT	SRF.365,SRF.370
MP:0001728	failure of embryo implantation	5	457	1.879655e-05	1.141703e-01	2.498255e-04	3.252357e+02	6.149386e-03	556	2	1.106005e-05	3.597122e-03	35	2.659076e-02	1.000000e+00	1.000000e+00	7.811706e+00	2.560260e-01	17217	19	232	2	8.620690e-03	1.052632e-01	HMX3,VEZT	SRF.370,SRF.382
MP:0003693	abnormal embryo hatching	4	469	2.383432e-05	1.447697e-01	3.086773e-04	2.887513e+02	6.926376e-03	556	2	1.245751e-05	3.597122e-03	79	4.753576e-02	1.000000e+00	1.000000e+00	5.708554e+00	3.503514e-01	17217	26	232	2	8.620690e-03	7.692308e-02	AURKA,VEZT	SRF.365,SRF.370
MP:0002636	delayed vaginal opening	8	494	4.077184e-05	2.476481e-01	5.013120e-04	2.206159e+02	9.065530e-03	556	2	1.630491e-05	3.597122e-03	13	1.091664e-02	1.000000e+00	1.000000e+00	1.236853e+01	1.617006e-01	17217	12	232	2	8.620690e-03	1.666667e-01	NR2F2,VGF	SRF.338,SRF.35
MP:0002563	shortened circadian period	6	503	4.379306e-05	2.659990e-01	5.288251e-04	2.128465e+02	9.396441e-03	556	2	1.690007e-05	3.597122e-03	52	3.208727e-02	1.000000e+00	1.000000e+00	7.067734e+00	2.829761e-01	17217	21	232	2	8.620690e-03	9.523810e-02	NR2F6,VGF	SRF.117,SRF.338
MP:0000420	ruffled hair	5	506	4.558424e-05	2.768786e-01	5.471910e-04	2.086096e+02	9.587284e-03	556	2	1.724332e-05	3.597122e-03	52	3.208727e-02	1.000000e+00	1.000000e+00	7.067734e+00	2.829761e-01	17217	21	232	2	8.620690e-03	9.523810e-02	NR4A1,NR4A3	SRF.176,SRF.21
MP:0005478	decreased circulating thyroxine level	7	514	4.935986e-05	2.998118e-01	5.832915e-04	2.004465e+02	9.977725e-03	556	2	1.794555e-05	3.597122e-03	79	4.753576e-02	1.000000e+00	1.000000e+00	5.708554e+00	3.503514e-01	17217	26	232	2	8.620690e-03	7.692308e-02	B4GALT1,VGF	SRF.338,SRF.97
MP:0001938	delayed sexual maturation	7	529	6.225971e-05	3.781655e-01	7.148686e-04	1.784039e+02	1.121052e-02	556	2	2.016281e-05	3.597122e-03	32	2.400176e-02	1.000000e+00	1.000000e+00	8.245690e+00	2.425510e-01	17217	18	232	2	8.620690e-03	1.111111e-01	NR2F2,VGF	SRF.338,SRF.35
MP:0009749	enhanced behavioral response to addictive substance	6	531	6.661910e-05	4.046444e-01	7.620422e-04	1.724458e+02	1.159785e-02	556	2	2.085944e-05	3.597122e-03	79	4.753576e-02	1.000000e+00	1.000000e+00	5.708554e+00	3.503514e-01	17217	26	232	2	8.620690e-03	7.692308e-02	HOMER1,NR4A2	SRF.26,SRF.450
MP:0004809	increased hematopoietic stem cell number	5	555	9.116694e-05	5.537480e-01	9.977442e-04	1.473154e+02	1.357631e-02	556	2	2.441783e-05	3.597122e-03	52	3.208727e-02	1.000000e+00	1.000000e+00	7.067734e+00	2.829761e-01	17217	21	232	2	8.620690e-03	9.523810e-02	NR4A1,NR4A3	SRF.176,SRF.21
MP:0006214	asymmetrical orbits	5	567	1.056293e-04	6.415921e-01	1.131556e-03	9.466575e+03	1.056348e-04	556	1	1.899907e-07	1.798561e-03	18	1.347505e-02	1.000000e+00	1.000000e+00	7.421121e+01	1.347505e-02	17217	1	232	1	4.310345e-03	1.000000e+00	RPL24	SRF.137
MP:0006011	abnormal endolymphatic duct morphology	5	577	1.182834e-04	7.184531e-01	1.245153e-03	1.292503e+02	1.547385e-02	556	2	2.783066e-05	3.597122e-03	74	4.107935e-02	1.000000e+00	1.000000e+00	6.184267e+00	3.234013e-01	17217	24	232	2	8.620690e-03	8.333333e-02	HMX3,NR4A3	SRF.176,SRF.382
MP:0008967	absent chiasmata formation	7	668	3.503040e-04	1.000000e+00	3.185249e-03	2.854165e+03	3.503652e-04	556	1	6.301533e-07	1.798561e-03	36	2.676930e-02	1.000000e+00	1.000000e+00	3.710560e+01	2.695011e-02	17217	2	232	1	4.310345e-03	5.000000e-01	CCNB1IP1	SRF.128
MP:0004061	papillary muscle hypoplasia	6	687	4.613409e-04	1.000000e+00	4.078871e-03	2.167095e+03	4.614472e-04	556	1	8.299409e-07	1.798561e-03	18	1.347505e-02	1.000000e+00	1.000000e+00	7.421121e+01	1.347505e-02	17217	1	232	1	4.310345e-03	1.000000e+00	MOSPD3	SRF.471
MP:0009121	increased white fat cell lipid droplet size	7	711	6.827946e-04	1.000000e+00	5.833044e-03	1.464070e+03	6.830274e-04	556	1	1.228467e-06	1.798561e-03	18	1.347505e-02	1.000000e+00	1.000000e+00	7.421121e+01	1.347505e-02	17217	1	232	1	4.310345e-03	1.000000e+00	JMJD1A	SRF.42
MP:0005433	absent early pro-B cells	10	720	7.434476e-04	1.000000e+00	6.271807e-03	1.344585e+03	7.437236e-04	556	1	1.337632e-06	1.798561e-03	36	2.676930e-02	1.000000e+00	1.000000e+00	3.710560e+01	2.695011e-02	17217	2	232	1	4.310345e-03	5.000000e-01	MCL1	SRF.87
MP:0009464	abnormal conus arteriosus morphology	7	726	8.215913e-04	1.000000e+00	6.873755e-03	1.216651e+03	8.219284e-04	556	1	1.478289e-06	1.798561e-03	36	2.676930e-02	1.000000e+00	1.000000e+00	3.710560e+01	2.695011e-02	17217	2	232	1	4.310345e-03	5.000000e-01	MOSPD3	SRF.471
MP:0005210	disorganized gastric mucosa	8	733	8.898163e-04	1.000000e+00	7.373457e-03	1.123328e+03	8.902117e-04	556	1	1.601100e-06	1.798561e-03	66	3.988516e-02	1.000000e+00	1.000000e+00	2.473707e+01	4.042516e-02	17217	3	232	1	4.310345e-03	3.333333e-01	IQGAP1	SRF.161
MP:0009120	abnormal white fat cell lipid droplet size	6	735	9.191652e-04	1.000000e+00	7.595931e-03	1.087445e+03	9.195871e-04	556	1	1.653934e-06	1.798561e-03	66	3.988516e-02	1.000000e+00	1.000000e+00	2.473707e+01	4.042516e-02	17217	3	232	1	4.310345e-03	3.333333e-01	JMJD1A	SRF.42
MP:0008009	delayed cellular replicative senescence	5	736	9.644502e-04	1.000000e+00	7.959335e-03	1.036361e+03	9.649148e-04	556	1	1.735458e-06	1.798561e-03	66	3.988516e-02	1.000000e+00	1.000000e+00	2.473707e+01	4.042516e-02	17217	3	232	1	4.310345e-03	3.333333e-01	ING1	SRF.438
MP:0003342	accessory spleen	5	746	1.092326e-03	1.000000e+00	8.893815e-03	9.149787e+02	1.092922e-03	556	1	1.965686e-06	1.798561e-03	36	2.676930e-02	1.000000e+00	1.000000e+00	3.710560e+01	2.695011e-02	17217	2	232	1	4.310345e-03	5.000000e-01	MEGF8	SRF.61
MP:0004332	utricular degeneration	8	748	1.149456e-03	1.000000e+00	9.333953e-03	8.694774e+02	1.150116e-03	556	1	2.068554e-06	1.798561e-03	36	2.676930e-02	1.000000e+00	1.000000e+00	3.710560e+01	2.695011e-02	17217	2	232	1	4.310345e-03	5.000000e-01	HMX3	SRF.382
MP:0009066	decreased oviduct weight	10	783	1.847390e-03	1.000000e+00	1.433084e-02	5.408049e+02	1.849096e-03	556	1	3.325712e-06	1.798561e-03	36	2.676930e-02	1.000000e+00	1.000000e+00	3.710560e+01	2.695011e-02	17217	2	232	1	4.310345e-03	5.000000e-01	VGF	SRF.338
MP:0003714	absent platelets	9	813	2.690555e-03	1.000000e+00	2.010139e-02	3.711712e+02	2.694174e-03	556	1	4.845637e-06	1.798561e-03	36	2.676930e-02	1.000000e+00	1.000000e+00	3.710560e+01	2.695011e-02	17217	2	232	1	4.310345e-03	5.000000e-01	MEIS1	SRF.446
MP:0004650	increased lumbar vertebrae number	8	866	3.902618e-03	1.000000e+00	2.737240e-02	2.557388e+02	3.910239e-03	556	1	7.032805e-06	1.798561e-03	66	3.988516e-02	1.000000e+00	1.000000e+00	2.473707e+01	4.042516e-02	17217	3	232	1	4.310345e-03	3.333333e-01	RPL24	SRF.137
MP:0004785	abnormal posterior cardinal vein morphology	7	867	3.961720e-03	1.000000e+00	2.775488e-02	2.519162e+02	3.969574e-03	556	1	7.139521e-06	1.798561e-03	18	1.347505e-02	1.000000e+00	1.000000e+00	7.421121e+01	1.347505e-02	17217	1	232	1	4.310345e-03	1.000000e+00	NR2F2	SRF.35
MP:0000046	abnormal sulcus ampullaris morphology	5	880	4.235285e-03	1.000000e+00	2.923309e-02	2.356122e+02	4.244263e-03	556	1	7.633567e-06	1.798561e-03	66	3.988516e-02	1.000000e+00	1.000000e+00	2.473707e+01	4.042516e-02	17217	3	232	1	4.310345e-03	3.333333e-01	NR4A3	SRF.176
